InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Piccina Cintia. Director active across 3 companies, notably Adaptimmune Therapeutics PLC. Aggregated, 7 reports have been recorded. Split: 0 buy · 5 sells. Total volume traded: €99k. Activity tracked since 1 August 2022. The latest transaction was filed on 1 September 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Piccina Cintia is a declarant associated with 5 filings in total. In the 5 recent filings available, they relate to sales, with EUR 85,333 of selling and no buying, between 2022-08-01 and 2025-01-15. The companies mentioned are Adaptimmune Therapeutics PLC and Allovir, Inc., where the listed role is Chief Commercial Officer.